Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Tracking Peripheral Nerve Wallerian Degeneration Using Ferrumoxytol and Serum Biomarkers

Award Number: R21NS153375
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/18/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Tracking Peripheral Nerve Wallerian Degeneration Using Ferrumoxytol and Serum Biomarkers - PROJECT SUMMARY Diagnostic evaluation of peripheral nerve injuries (PNIs) currently relies on a subjective clinical examination, electrodiagnostic testing (EDX), and imaging. However, EDX, is unreliable acutely (<4 weeks post injury), at a time when it is most critical to understand the severity of a nerve injury. Conventional imaging can detect whether a nerve is ruptured but is not reliable in discerning whether stretch or crush injuries will or will not recover. This limitation is particularly problematic when treating nerve injuries, as surgical intervention should be performed as early as possible to improve the chance of recovery. Radiologists at Hospital for Special Surgery and peripheral nerve surgeons at Washington University in St. Louis will combine a novel contrast agent for MR neurography with novel use of blood biomarkers in an innovative surgical technique to accurately diagnosis peripheral nerve injury. Aim 1: Serum neurofilament light chain (sNfL) and peripherin are protein markers released into the bloodstream after nerve injury will detect the presence of and depict the severity of nerve injury. Aim 2: Detection of Wallerian degeneration that occurs in nerve injury can be identified using MR neurography with ferumoxytol, an ultrasmall, superparamagnetic iron oxide imaging (USPIO) contrast agent that is taken up by macrophages involved in nerve degeneration. Quantitative MRI will also evaluate for acute changes of increased muscle perfusion and muscle edema that ensue with denervation. This project will investigate the relationship of location and timing of nerve injury with these serum and imaging biomarkers using an innovative and reproducible clinical paradigm: a surgical, human nerve injury model comprising a clinically indicated below-the-knee amputation (BKA) that includes a deliberate transection of the common peroneal nerve (CPN), retention of the transected stump and transfer of the proximal nerve into the lateral gastrocnemius motor branch. Longitudinal assessments in n=15 BKA patients, at baseline post-surgery, 6-weeks, and 6-months post-surgery will characterize temporal changes in both serum and imaging biomarkers. This project will develop novel diagnostic algorithms to facilitate early identification of location and degree of peripheral nerve injury. This paves the way for future validation of such an algorithm in larger clinical trials towards a paradigm shift in expeditious care of peripheral nerve injuries and improved patient care outcomes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $462,806 )
2026	2026	WASHINGTON UNIVERSITY, THE	1 BROOKINGS DR	SAINT LOUIS	MO	63130	SAINT LOUIS	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	9/17/2026	NEW	$462,806
														Subtotal = $462,806

Grand Total All Awards = $462,806

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Tracking Peripheral Nerve Wallerian Degeneration Using Ferrumoxytol and Serum Biomarkers

Award Number: R21NS153375

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/18/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer